TY  - GEN
AU  - Aleksenko,Svetlana S
AU  - Matczuk,Magdalena
AU  - Lu,Xifeng
AU  - Foteeva,Lidia S
AU  - Pawlak,Katarzyna
AU  - Timerbaev,Andrei R
AU  - Jarosz,Maciej
TI  - Metallomics for drug development: an integrated CE-ICP-MS and ICP-MS approach reveals the speciation changes for an investigational ruthenium(III) drug bound to holo-transferrin in simulated cancer cytosol
SN  - 1756-591X
PY  - 2014///0227
KW  - Antineoplastic Agents
KW  - chemistry
KW  - Ascorbic Acid
KW  - Blood Proteins
KW  - Cell Proliferation
KW  - drug effects
KW  - Cytosol
KW  - Drug Design
KW  - Electrophoresis, Capillary
KW  - methods
KW  - Glutathione
KW  - Humans
KW  - Ligands
KW  - Mass Spectrometry
KW  - Neoplasms
KW  - pathology
KW  - Oxidation-Reduction
KW  - Protein Binding
KW  - Ruthenium
KW  - Time Factors
KW  - Transferrin
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1039/c3mt00092c
ER  -